{"gene":"RFC1","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":1993,"finding":"PO-GA (RFC1) was identified as a human DNA-binding protein that selectively binds GA-rich double-stranded DNA sequences and certain single-stranded DNA sequences. The protein has regions of homology to E. coli and yeast DNA ligases and to proteins involved in DNA repair, suggesting roles in transcription, DNA repair, or replication.","method":"HeLa cDNA expression library screening with cognate DNA binding site; E. coli expression and DNA-binding assay; Northern blot","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single lab, direct DNA-binding assay in vitro, but limited functional follow-up; no mutagenesis or reconstitution","pmids":["8512577"],"is_preprint":false},{"year":1994,"finding":"PO-GA was shown to be 80% identical at the amino-acid level to the large subunit of mouse replication factor C (RFC), establishing it as the human RFC1 large subunit. The protein contains a nuclear translocation signal and an ATP/ADP-binding motif. Two mRNA species (5.3 kb and 4.5 kb) arise from alternate use of poly(A)-addition sites, with expression levels varying by tissue.","method":"DNA sequence database comparison; Northern blot of human tissues; cDNA sequence analysis of 3'-UTR","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — sequence identity establishes orthology, alternate poly(A) site mechanism shown by sequence analysis and Northern blot, single lab","pmids":["7914507"],"is_preprint":false},{"year":1995,"finding":"RFC1 encodes the reduced folate carrier protein responsible for methotrexate (MTX) uptake in human breast cancer cells. Decreased RFC1 expression was the molecular mechanism of decreased MTX uptake in MTX-resistant ZR-75-1 cells; transfection with RFC1 restored MTX uptake with folinic acid competition preference over folic acid.","method":"Northern blot; Western blot with anti-RFC1 peptide antibody; cDNA transfection into transport-deficient cells; MTX uptake competition assay; FISH chromosomal mapping","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Western, Northern, functional transfection rescue, uptake assay) in single lab; finding replicated across multiple subsequent papers","pmids":["7641195"],"is_preprint":false},{"year":1997,"finding":"RFC1 functions as a bidirectional anion exchanger/reduced folate carrier. High-level RFC1 overexpression via transfection increased MTX influx ~9-fold and efflux ~5-fold but produced only a modest (~2-fold) increase in steady-state intracellular MTX, consistent with RFC1 being intrinsically equilibrating rather than concentrative. Free intracellular folate levels, not influx rate, determined antifolate activity.","method":"cDNA transfection of RFC1 into MTXrA carrier-null cells; radiolabeled MTX influx/efflux kinetics; intracellular MTX concentration measurement; IC50 determination","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — quantitative transport reconstitution by transfection with kinetic analysis; multiple functional readouts; consistent with structural model of bidirectional exchanger","pmids":["9261128"],"is_preprint":false},{"year":1997,"finding":"The murine RFC-1 gene spans 10.4 kb and is distributed in eight exons including alternates of exon 1 and exon 5. Splice variants encoding polypeptides of 58, 53.6, and 43.4 kDa arise from alternate exon usage. A GC-rich region 5' of exon 1 contains promoter-like elements. Two distinct promoters drive RFC-1 transcription.","method":"Genomic DNA sequencing; cDNA library screening; splice variant identification; gene structure mapping","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — structural genomic characterization of gene organization and splice variants; functional promoter activity not yet tested in this paper","pmids":["9161403"],"is_preprint":false},{"year":1998,"finding":"A glutamate-to-lysine mutation at amino acid 45 (E45K) in the first predicted transmembrane domain of murine RFC1 markedly altered substrate specificity: folic acid influx doubled while MTX and 5-CHO-THF influx decreased. The E45K mutant carrier required small inorganic anions (chloride, fluoride, nitrate) for transport function, whereas the wild-type did not show this obligatory anion requirement. This indicates that the first transmembrane domain is critical for determining the spectrum of substrate affinities and carrier mobility.","method":"cDNA transfection of RFC1-E45K into carrier-null MTXrA cells; radiolabeled substrate influx assays; anion substitution experiments; inhibition kinetics","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — site-specific mutation reconstituted in null background with multiple substrate and anion-replacement experiments; mechanistic interpretation supported by quantitative kinetics","pmids":["9668089"],"is_preprint":false},{"year":1998,"finding":"A single amino acid difference at codon 297 (Ser in L1210 vs. Asn in S180 cells), located between transmembrane helices 7 and 8, accounts for a 4-fold higher influx Km for MTX in S180 cells without affecting Vmax or efflux. This residue is on or near the external substrate-binding site and selectively affects N1O-substituted folate analogues. The topology analysis places the codon-297 region on the external plasma membrane surface.","method":"Nucleotide sequencing of cDNA and genomic DNA; cDNA transfection of S180 vs. L1210 RFC-1 cDNAs into carrier-null L1210 variant; radiolabeled MTX/aminopterin influx Km measurements; Western blot; topology analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — single nucleotide difference identified and functionally confirmed by reciprocal cDNA transfection into null background with quantitative kinetics","pmids":["9446553"],"is_preprint":false},{"year":1998,"finding":"The human RFC-1 gene spans 22.5 kb and contains eight exons including three alternatives of exon 1 (1a, 1b, 1c). Two distinct promoters were identified upstream of exons 1a/1c and 1b respectively by functional deletion analysis. Promoter 1 (upstream of exon 1a) had ~3-fold lower basal activity than promoter 2 (upstream of exon 1b), but was enhanced up to 9-fold with an SV40 enhancer. Promoter 2 contains a GC-rich direct repeat with Sp1 and MZF1 sites.","method":"Genomic DNA sequencing; primer extension analysis; luciferase reporter gene transient transfection in two human cell types; functional deletion analysis","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — dual-promoter activity demonstrated by reporter assays in cells; primer extension confirms multiple transcription start sites; single lab","pmids":["9602167"],"is_preprint":false},{"year":1998,"finding":"A mutation in the large subunit of yeast RFC (rfc1-1, D513N) within the conserved RFC box VIII sequence causes DNA replication defects, increased sensitivity to DNA-damaging agents, elongated telomeres, and in vitro DNA replication defects. Destabilized PCNA trimers (mutant PCNA) suppress the in vitro replication defects of rfc1-1 mutant complexes in an ATP-concentration-sensitive manner, suggesting that RFC1-PCNA interaction and PCNA clamp loading are mechanistically linked.","method":"Yeast genetics; in vitro DNA replication assay; PCNA mutant suppressor analysis; DNA damage sensitivity assay; telomere length analysis","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of replication defect with defined mutation; PCNA suppression tested biochemically; multiple in vivo phenotypes","pmids":["9521689"],"is_preprint":false},{"year":1998,"finding":"RFC1 gene copy number amplification at a homogeneously staining region (HSR) in a chromosome 10 locus in the L1210/R83 variant underlies a 30-35-fold increase in RFC-1 mRNA and a 35-fold increase in MTX transport Vmax. Chromosomal localization of murine RFC-1 gene is on chromosome 10B3 in association with the Col18a1 collagen gene.","method":"Southern blot (gene copy number); Northern blot (mRNA levels); FISH (chromosomal localization and HSR identification); MTX influx Vmax measurement; karyotype analysis","journal":"Cancer genetics and cytogenetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — FISH directly localized amplified RFC-1 to HSR; multiple orthogonal methods in single lab; functional correlation between gene dosage and transport capacity","pmids":["9689927"],"is_preprint":false},{"year":1999,"finding":"The rfc1::Tn3 (large subunit of yeast clamp loader RFC) mutant displays a mutator phenotype and repeat-tract instability. Genetic epistasis analysis shows that rfc1::Tn3 is synthetically lethal with pol30 (PCNA), pol3 (DNA Pol δ), and rad27 (Fen1) mutations. The rfc1::Tn3 forward mutation frequency is nearly multiplicative with mismatch repair mutants (msh2Δ, pms1Δ), but its repeat-tract instability phenotype is epistatic to mismatch repair mutants, indicating RFC1 generates replication errors that are partially corrected by MMR.","method":"Yeast genetic screen; forward mutation assay; repeat-tract instability assay; double and triple mutant analysis with msh2Δ, pms1Δ, rad52, pol3-01, pol30-52, rth1Δ/rad27Δ; synthetic lethality testing","journal":"Genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple epistasis combinations tested with defined alleles; quantitative mutation frequency in double mutants; clear pathway placement of RFC1 relative to MMR and DNA replication","pmids":["9927446"],"is_preprint":false},{"year":1999,"finding":"RFC1 RNA levels are cell-cycle regulated and peak at the G1-to-S transition. Differential transcription from multiple RFC1 5' non-coding exons occurs in different tissues, during development, and in MTX-resistant cells. Genomic sequences upstream of exons 1b and 1c contain functional promoter elements, identified by promoter-reporter fusion constructs.","method":"Semi-quantitative RT-PCR with exon-specific primers; RFC1 promoter-reporter fusion constructs; Northern blot","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional promoter activity demonstrated; cell cycle regulation established by RT-PCR across cell cycle stages; single lab","pmids":["10375617"],"is_preprint":false},{"year":1999,"finding":"Two promoters regulating mouse RFC-1 gene expression were functionally characterized. The promoter upstream of exon 1 (stronger) and the promoter upstream of exon 1a (weaker) each rely on closely spaced tandem Sp1 sites for basal promoter activity, as demonstrated by site-directed mutagenesis and DNase I footprinting. A poly(GT)21 dinucleotide repeat upstream of the Sp1 sites suppresses transcription when deleted.","method":"Luciferase reporter gene transient transfection in NIH3T3 cells; site-directed mutagenesis of Sp1 sites; DNase I footprinting analysis","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — site-directed mutagenesis with reporter assay and footprinting confirms Sp1-dependent mechanism; single lab","pmids":["10231581"],"is_preprint":false},{"year":2000,"finding":"Exposure of ZR-75-1 breast cancer cells to low-dose MTX caused transcriptional down-regulation of RFC1: RFC1 RNA and protein levels decreased to ~22% of baseline, and promoter-reporter assays showed decreased activity of RFC1 promoter elements. This down-regulation was not due to DNA methylation of the RFC1 promoter (5-azacytidine pretreatment did not restore RFC1 activity).","method":"Western blot; Northern blot; RT-PCR with exon-specific primers; promoter-reporter construct assays; MTX uptake measurement; 5-azacytidine pretreatment experiment","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (Western, Northern, RT-PCR, reporter assay) demonstrating transcriptional down-regulation; negative result on methylation mechanism informative; single lab","pmids":["11162445"],"is_preprint":false},{"year":2000,"finding":"Allele-specific genetic interactions between yeast RFC1 and RFC5 genes were identified: RFC5 mutations in conserved RFC box motifs IV-VII suppress the cold-sensitive growth phenotype of rfc1-1 mutants but cannot suppress its elongated telomere, DNA-damage sensitivity, or mutator phenotypes. RFC5 suppressor mutations do not interfere with checkpoint signaling (Rad53p phosphorylation). This defines distinct functional contributions of RFC1 and RFC5 to telomere maintenance, DNA repair, and viability versus checkpoint function.","method":"Yeast genetics; allele-specific suppressor isolation; phenotypic analysis (growth, DNA damage sensitivity, telomere length, mutation frequency); Rad53p phosphorylation assay (Western blot)","journal":"Molecular & general genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — allele-specific suppression with multiple phenotypic readouts; clear genetic dissection of RFC1 functions; single lab","pmids":["11129041"],"is_preprint":false},{"year":2007,"finding":"Drosophila rfc1 gene (encoding dRFC140, the large RFC subunit) is transcriptionally regulated by the DRE-DREF pathway. Three DRE-like sequences in the rfc1 promoter bind DREF in vitro (EMSA with nuclear extracts) and in vivo (chromatin immunoprecipitation). Luciferase reporter assays confirm that DREs are required for full rfc1 promoter activity in S2 cells; DREF dsRNA knockdown reduced rfc1 promoter activity by 38%. Immunostaining shows rfc1 expression correlates with cell-cycle stage.","method":"Band-mobility shift assay (EMSA); chromatin immunoprecipitation; luciferase transient expression assay in S2 cells; DREF dsRNA knockdown; immunostaining of polytene chromosomes and larval tissues","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (EMSA, ChIP, reporter assay, RNAi) converging on DRE-DREF regulation; in vivo and in vitro concordance; single lab","pmids":["17381512"],"is_preprint":false},{"year":2012,"finding":"RFC1-RFC (the canonical clamp loader) is required for PCNA-CRL4(Cdt2)-mediated Cdt1 degradation specifically after UV irradiation (during nucleotide excision repair), but not during S phase. A distinct RFC complex, Ctf18-RFC, is required for Cdt1 degradation during S phase. Thus, different RFC complexes differentially control CRL4(Cdt2)-dependent proteolysis of Cdt1 during replication versus repair.","method":"siRNA depletion of RFC1 and Ctf18 in human cells; flow cytometry and Western blot of Cdt1 stability; chromatin fractionation for PCNA loading; re-replication assay; Cdt1 degron mutant constructs","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean siRNA knockdown with defined phenotype; multiple cell-cycle and repair conditions tested; pathway placement by depletion of individual RFC complex components with specific readout","pmids":["22493068"],"is_preprint":false},{"year":2019,"finding":"Biallelic intronic AAGGG repeat expansion in RFC1 intron 2 (within the poly(A) tail of an AluSx3 element) is the genetic cause of CANVAS and late-onset ataxia. Critically, the expansion does not affect RFC1 expression in patient peripheral and brain tissue, suggesting the pathogenic mechanism is not simple loss of RFC1 protein function.","method":"Non-parametric linkage analysis; genome sequencing; quantitative expression analysis in patient peripheral and brain tissue; repeat-primed PCR; Southern blot","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide linkage analysis followed by molecular characterization in multiple families; expression analysis in patient tissues; widely replicated across subsequent studies","pmids":["30926972"],"is_preprint":false},{"year":2022,"finding":"Truncating variants (nonsense and frameshift) in RFC1, when compound heterozygous with the AAGGG repeat expansion, cause CANVAS. Patient fibroblasts with truncating variants show nonsense-mediated mRNA decay and reduced RFC1 transcript and protein levels, providing evidence that a loss-of-function mechanism underlies RFC1-related CANVAS.","method":"Whole-genome/exome sequencing; RT-PCR quantification of RFC1 transcript; Western blot of RFC1 protein in patient fibroblasts; nonsense-mediated decay assessment","journal":"Neurology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple independent families; direct measurement of transcript and protein in patient-derived cells; multiple truncating variants with concordant NMD; replicated across two independent papers (PMIDs 36289003, 35883251)","pmids":["36289003","35883251","36524104","36250766"],"is_preprint":false},{"year":2022,"finding":"RFC1 expression studies in whole blood from CANVAS patients compound heterozygous for truncating variants and AAGGG expansion showed significantly reduced RFC1 mRNA compared with patients carrying biallelic RFC1 expansions alone, providing additional evidence for conditional loss-of-function as a disease mechanism.","method":"Quantitative RT-PCR of RFC1 mRNA in patient whole blood; clinical exome sequencing; repeat-primed PCR for expansion identification","journal":"Brain","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — quantitative mRNA measurement in patient blood; single lab; limited sample size (n=2 truncating variant patients vs. 3 biallelic expansion patients)","pmids":["35883251"],"is_preprint":false},{"year":2023,"finding":"Pathogenic CANVAS-causing RFC1 repeat motifs (AAGGG and ACAGG) but not nonpathogenic motifs (AAAAG) form G-quadruplex structures (in potassium solution) and triple-stranded structures. The pathogenic motif r(AAGGG)4 forms G-quadruplexes detectable with the ligand TMPyP4. Nonpathogenic repeats do not form these structures. This supports toxic-DNA and toxic-RNA modes of pathogenesis via unusual nucleic acid secondary structures.","method":"In vitro biophysical characterization of synthetic DNA/RNA oligonucleotides; G-quadruplex detection in potassium solution; triplex structure formation assays; TMPyP4 ligand-binding assay; computational analysis of hydrogen bonds and pi-stacking","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with defined oligonucleotides; multiple structural assays; single lab; correlative link to pathogenicity requires further cellular validation","pmids":["37660923"],"is_preprint":false},{"year":2024,"finding":"CCCTT/AAGGG repeat expansions in CANVAS patient iPSC-derived neurons do not alter RFC1 splicing, expression, or DNA repair pathway function. CANVAS iNeurons exhibit defects in neuronal development and diminished synaptic connectivity that is rescued by CRISPR deletion of a single expanded AAGGG allele. These neuronal deficits were NOT replicated by RFC1 knockdown in control neurons and were NOT rescued by RFC1 reprovision, establishing that the pathogenic mechanism is repeat-dependent but RFC1 protein-independent.","method":"Patient iPSC-derived neuron generation; calcium imaging; transcriptomics; CRISPR allele deletion; RFC1 knockdown (siRNA/shRNA); RFC1 overexpression/reprovision; RT-PCR for RFC1 splicing; DNA repair pathway functional assays","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods; CRISPR rescue confirms repeat dependence; RFC1 knockdown/reprovision negative results are mechanistically informative; replicated in preprint (PMID 38168171)","pmids":["39231235"],"is_preprint":false},{"year":2023,"finding":"CCCTT- and CCCGT-containing RNA foci were detected by RNA FISH in neuronal nuclei of tissues with neuronal loss in two autopsy CANVAS patients with biallelic ACAGG and AAGGG expansions, respectively. This suggests that RNA toxicity (toxic RNA gain-of-function) may contribute to CANVAS pathogenesis.","method":"RNA fluorescence in situ hybridization (FISH) on autopsy tissue; neuropathological analysis","journal":"Annals of neurology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab; only two autopsy cases; correlative finding without functional manipulation to establish causality","pmids":["38062616"],"is_preprint":false}],"current_model":"RFC1 encodes the large subunit of the replication factor C (RFC) clamp loader complex, which loads the PCNA sliding clamp onto DNA at primer-template junctions in an ATP-dependent manner and is required for DNA replication fidelity, repair, and telomere maintenance; it also functions as a bidirectional anion exchanger/reduced folate carrier (SLC19A1) at the plasma membrane, transporting reduced folates and antifolates including methotrexate via a mechanism requiring the first transmembrane domain for substrate selectivity; RFC1-RFC specifically mediates PCNA-CRL4(Cdt2)-dependent Cdt1 proteolysis after UV damage but not during S phase; biallelic intronic AAGGG repeat expansions cause CANVAS via a repeat-dependent but RFC1 protein-independent mechanism (neuronal synaptic dysfunction rescued by CRISPR deletion of expanded alleles but not by RFC1 knockdown/reprovision), with pathogenic repeat motifs forming G-quadruplex and triplex structures in vitro, while truncating variants in compound heterozygosity with the expansion cause disease through partial RFC1 loss-of-function via nonsense-mediated mRNA decay."},"narrative":{"mechanistic_narrative":"RFC1 encodes the large subunit of the replication factor C (RFC) clamp loader, an ATP-utilizing complex that loads the PCNA sliding clamp onto DNA and thereby underpins DNA replication fidelity, repair, and telomere maintenance [PMID:9521689, PMID:9927446]. It was first cloned as a GA-rich DNA-binding protein carrying an ATP/ADP-binding motif and nuclear localization signal, and assigned as the human ortholog of the mouse RFC large subunit [PMID:8512577, PMID:7914507]. Yeast genetics establishes the mechanistic core: RFC1 mutation produces DNA replication defects, DNA-damage sensitivity, elongated telomeres and a mutator/repeat-instability phenotype, and RFC1 is synthetically lethal with PCNA, DNA Pol δ and Fen1, with destabilized PCNA trimers suppressing its replication defect — directly coupling RFC1 to PCNA clamp loading [PMID:9521689, PMID:9927446]; allele-specific interactions with RFC5 further partition RFC1's roles in telomere maintenance, repair and viability from checkpoint signaling [PMID:11129041]. RFC1 RNA peaks at the G1-to-S transition under control of dual GC-rich, Sp1-dependent promoters, a cell-cycle program conserved through the Drosophila DRE-DREF pathway [PMID:10375617, PMID:10231581, PMID:17381512]. Within the clamp-loader family, RFC1-RFC selectively drives PCNA-CRL4(Cdt2)-mediated Cdt1 degradation after UV damage, whereas Ctf18-RFC handles Cdt1 turnover during S phase [PMID:22493068]. Independently, the same locus (SLC19A1) encodes the reduced folate carrier, a bidirectional, equilibrating anion exchanger at the plasma membrane that mediates uptake of reduced folates and antifolates including methotrexate; its first transmembrane domain (E45) determines substrate selectivity and anion dependence, and a residue near helices 7-8 (codon 297) tunes the influx Km for N10-substituted folates [PMID:7641195, PMID:9261128, PMID:9668089, PMID:9446553]. Biallelic intronic AAGGG repeat expansions in RFC1 cause CANVAS and late-onset ataxia without altering RFC1 expression [PMID:30926972]; iPSC-neuron work shows the synaptic and developmental deficits are rescued by CRISPR deletion of the expanded allele but not reproduced by RFC1 knockdown or rescued by RFC1 reprovision, establishing a repeat-dependent, RFC1-protein-independent mechanism [PMID:39231235], with pathogenic motifs forming G-quadruplex and triplex structures in vitro [PMID:37660923]. In compound heterozygosity with the expansion, truncating variants cause disease through partial loss of function via nonsense-mediated mRNA decay [PMID:36289003, PMID:35883251, PMID:36524104, PMID:36250766].","teleology":[{"year":1994,"claim":"Establishing that the cloned GA-rich DNA-binding protein PO-GA is the human RFC large subunit answered what this protein is and pointed toward replication/repair function via its ATP-binding motif.","evidence":"cDNA expression cloning by DNA-binding, sequence comparison to mouse RFC, Northern blot of human tissues","pmids":["8512577","7914507"],"confidence":"Medium","gaps":["DNA-binding specificity not linked to a defined replication step","No reconstitution of clamp-loading activity"]},{"year":1997,"claim":"Demonstrating that the same locus encodes the reduced folate carrier resolved its second identity as a membrane transporter and explained methotrexate uptake and resistance.","evidence":"cDNA transfection rescue of transport-deficient cells, MTX influx/efflux kinetics, uptake competition assays","pmids":["7641195","9261128"],"confidence":"High","gaps":["Transport mechanism (equilibrating vs concentrative) defined functionally but not structurally","Relationship between transporter role and RFC clamp-loader role unexplained"]},{"year":1998,"claim":"Site-directed and natural variant analysis mapped the structural determinants of folate/antifolate substrate selectivity, showing specific transmembrane residues set substrate spectrum and anion dependence.","evidence":"E45K and codon-297 mutants reconstituted in carrier-null cells with substrate influx Km/Vmax and anion-substitution kinetics","pmids":["9668089","9446553"],"confidence":"High","gaps":["No high-resolution structure of the carrier","Full transport cycle not modeled"]},{"year":1999,"claim":"Yeast genetics placed RFC1 mechanistically within PCNA clamp loading and replication-error suppression, defining its epistatic relationships with PCNA, Pol δ, Fen1 and mismatch repair and separating its functions from checkpoint signaling.","evidence":"Yeast rfc1 mutants/Tn3 alleles, in vitro replication assays with PCNA suppressors, synthetic lethality and mutation-frequency epistasis, allele-specific RFC5 suppression","pmids":["9521689","9927446","11129041"],"confidence":"High","gaps":["Human RFC1 clamp-loading not directly reconstituted in these studies","Telomere maintenance role mechanistically undefined"]},{"year":1999,"claim":"Promoter and cell-cycle expression analysis showed RFC1 transcription is coordinated with the G1/S transition through Sp1-dependent dual promoters, a regulatory logic conserved to the Drosophila DRE-DREF pathway.","evidence":"RT-PCR across cell cycle, reporter/footprinting promoter dissection, EMSA/ChIP/RNAi in Drosophila S2 cells","pmids":["10375617","10231581","9602167","17381512","11162445"],"confidence":"Medium","gaps":["Upstream signals coupling RFC1 transcription to cell-cycle machinery not fully defined","MTX-induced down-regulation mechanism (non-methylation) incomplete"]},{"year":2012,"claim":"Distinguishing RFC1-RFC from Ctf18-RFC in CRL4(Cdt2)-dependent Cdt1 proteolysis defined a context-specific role for canonical RFC in coupling PCNA loading to ubiquitin-mediated degradation after UV damage rather than during S phase.","evidence":"siRNA depletion of RFC1 vs Ctf18 in human cells, Cdt1 stability by Western/flow, chromatin fractionation, re-replication assay","pmids":["22493068"],"confidence":"High","gaps":["Molecular basis of why RFC1-RFC acts only in repair context unknown","Direct interaction with CRL4(Cdt2) not structurally resolved"]},{"year":2019,"claim":"Linkage and genome sequencing identified biallelic intronic AAGGG repeat expansion as the cause of CANVAS, and the absence of expression change reframed the question away from simple RFC1 loss.","evidence":"Non-parametric linkage, genome sequencing, repeat-primed PCR/Southern, expression analysis in patient tissues","pmids":["30926972"],"confidence":"High","gaps":["Pathogenic mechanism of the repeat not established","Cell type and pathway driving neurodegeneration unknown"]},{"year":2022,"claim":"Identification of truncating variants in trans with the expansion, with NMD and reduced transcript/protein, established that a partial loss-of-function mechanism contributes to RFC1-related CANVAS.","evidence":"Exome/genome sequencing across families, RT-PCR transcript quantification, Western blot in patient fibroblasts and blood","pmids":["36289003","35883251","36524104","36250766"],"confidence":"High","gaps":["Reconciliation of loss-of-function with normal expression in biallelic-expansion patients incomplete","Quantitative dosage threshold for disease unknown"]},{"year":2023,"claim":"Biophysical and neuropathological work characterized the molecular nature of the repeat, showing pathogenic motifs uniquely form G-quadruplex/triplex structures and produce nuclear RNA foci, supporting toxic-DNA/RNA modes.","evidence":"In vitro G-quadruplex/triplex assays on synthetic oligonucleotides, RNA FISH on autopsy tissue","pmids":["37660923","38062616"],"confidence":"Medium","gaps":["Causal link between secondary structures and neuronal toxicity not established in vivo","RNA foci finding limited to two autopsy cases"]},{"year":2024,"claim":"iPSC-neuron modeling resolved the CANVAS mechanism as repeat-dependent but RFC1-protein-independent, since allele deletion rescued synaptic deficits while RFC1 knockdown failed to phenocopy and reprovision failed to rescue.","evidence":"Patient iPSC-derived neurons, calcium imaging, transcriptomics, CRISPR allele deletion, RFC1 knockdown and overexpression, DNA-repair assays","pmids":["39231235"],"confidence":"High","gaps":["Identity of the toxic species (DNA vs RNA vs RAN product) not pinned down","How repeat toxicity converges on synaptic connectivity unknown"]},{"year":null,"claim":"It remains unresolved how the repeat-dependent toxic mechanism mechanistically reconciles with the loss-of-function contribution of truncating variants, and what the toxic molecular species is.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking expansion toxicity and partial loss-of-function","Toxic species and its cellular target not identified","No structural model of human RFC1 clamp-loader function in this corpus"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[8,1]},{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[2,3,5,6]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[16]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,8]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,5,6]}],"pathway":[{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[8,10]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[16,10]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[2,3,5]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[17,18,21]}],"complexes":["Replication factor C (RFC) clamp loader"],"partners":["PCNA","RFC5","CDT1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P35251","full_name":"Replication factor C subunit 1","aliases":["Activator 1 140 kDa subunit","A1 140 kDa subunit","Activator 1 large subunit","Activator 1 subunit 1","DNA-binding protein PO-GA","Replication factor C 140 kDa subunit","RF-C 140 kDa subunit","RFC140","Replication factor C large subunit"],"length_aa":1148,"mass_kda":128.3,"function":"Subunit of the replication factor C (RFC) complex which acts during elongation of primed DNA templates by DNA polymerases delta and epsilon, and is necessary for ATP-dependent loading of proliferating cell nuclear antigen (PCNA) onto primed DNA (PubMed:9488738). This subunit binds to the primer-template junction. Binds the PO-B transcription element as well as other GA rich DNA sequences. Can bind single- or double-stranded DNA","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P35251/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/RFC1","classification":"Common Essential","n_dependent_lines":482,"n_total_lines":1208,"dependency_fraction":0.3990066225165563},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"H2AFZ","stoichiometry":0.2},{"gene":"HIST2H2BE","stoichiometry":0.2},{"gene":"NPM1","stoichiometry":0.2},{"gene":"NUCKS1","stoichiometry":0.2},{"gene":"PARP1","stoichiometry":0.2},{"gene":"PCNA","stoichiometry":0.2},{"gene":"PSPC1","stoichiometry":0.2},{"gene":"RPS16","stoichiometry":0.2},{"gene":"SRP9","stoichiometry":0.2},{"gene":"SSRP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/RFC1","total_profiled":1310},"omim":[{"mim_id":"614575","title":"CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS","url":"https://www.omim.org/entry/614575"},{"mim_id":"614041","title":"RB TRANSCRIPTIONAL COREPRESSOR 1; RB1","url":"https://www.omim.org/entry/614041"},{"mim_id":"609534","title":"ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 5; ATAD5","url":"https://www.omim.org/entry/609534"},{"mim_id":"609309","title":"MutS HOMOLOG 2; MSH2","url":"https://www.omim.org/entry/609309"},{"mim_id":"608749","title":"BROMODOMAIN-CONTAINING PROTEIN 4; BRD4","url":"https://www.omim.org/entry/608749"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RFC1"},"hgnc":{"alias_symbol":["A1","PO-GA","RFC140","MHCBFB"],"prev_symbol":[]},"alphafold":{"accession":"P35251","domains":[{"cath_id":"3.40.50.10190","chopping":"392-492","consensus_level":"high","plddt":83.0668,"start":392,"end":492},{"cath_id":"3.40.50.300","chopping":"604-619_641-703_711-835","consensus_level":"medium","plddt":84.6106,"start":604,"end":835},{"cath_id":"1.20.272.10","chopping":"846-960","consensus_level":"high","plddt":88.8517,"start":846,"end":960},{"cath_id":"-","chopping":"989-1068","consensus_level":"high","plddt":86.9907,"start":989,"end":1068}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P35251","model_url":"https://alphafold.ebi.ac.uk/files/AF-P35251-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P35251-F1-predicted_aligned_error_v6.png","plddt_mean":61.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RFC1","jax_strain_url":"https://www.jax.org/strain/search?query=RFC1"},"sequence":{"accession":"P35251","fasta_url":"https://rest.uniprot.org/uniprotkb/P35251.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P35251/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P35251"}},"corpus_meta":[{"pmid":"30926972","id":"PMC_30926972","title":"Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.","date":"2019","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30926972","citation_count":432,"is_preprint":false},{"pmid":"31230722","id":"PMC_31230722","title":"Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVAS.","date":"2019","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31230722","citation_count":192,"is_preprint":false},{"pmid":"7641195","id":"PMC_7641195","title":"Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells.","date":"1995","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/7641195","citation_count":187,"is_preprint":false},{"pmid":"33103729","id":"PMC_33103729","title":"A novel RFC1 repeat motif (ACAGG) in two Asia-Pacific CANVAS families.","date":"2020","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33103729","citation_count":80,"is_preprint":false},{"pmid":"32851396","id":"PMC_32851396","title":"A Māori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele.","date":"2020","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32851396","citation_count":65,"is_preprint":false},{"pmid":"9668089","id":"PMC_9668089","title":"A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9668089","citation_count":65,"is_preprint":false},{"pmid":"31824583","id":"PMC_31824583","title":"Investigation of the RFC1 Repeat Expansion in a Canadian and a Brazilian Ataxia Cohort: Identification of Novel Conformations.","date":"2019","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31824583","citation_count":64,"is_preprint":false},{"pmid":"37450567","id":"PMC_37450567","title":"Normal and pathogenic variation of RFC1 repeat expansions: implications for clinical diagnosis.","date":"2023","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/37450567","citation_count":61,"is_preprint":false},{"pmid":"9261128","id":"PMC_9261128","title":"Impact of overexpression of the reduced folate carrier (RFC1), an anion exchanger, on concentrative transport in murine L1210 leukemia cells.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9261128","citation_count":58,"is_preprint":false},{"pmid":"14632302","id":"PMC_14632302","title":"Genotype frequencies and linkage disequilibrium in the CEPH human diversity panel for variants in folate pathway genes MTHFR, MTHFD, MTRR, RFC1, and GCP2.","date":"2003","source":"Birth defects research. Part A, Clinical and molecular teratology","url":"https://pubmed.ncbi.nlm.nih.gov/14632302","citation_count":56,"is_preprint":false},{"pmid":"32939785","id":"PMC_32939785","title":"Biallelic Intronic AAGGG Expansion of RFC1 is Related to Multiple System Atrophy.","date":"2020","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32939785","citation_count":53,"is_preprint":false},{"pmid":"9446553","id":"PMC_9446553","title":"A single amino acid difference within the folate transporter encoded by the murine RFC-1 gene selectively alters its interaction with folate analogues. Implications for intrinsic antifolate resistance and directional orientation of the transporter within the plasma membrane of tumor cells.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9446553","citation_count":53,"is_preprint":false},{"pmid":"32582864","id":"PMC_32582864","title":"Prevalence of RFC1-mediated spinocerebellar ataxia in a North American ataxia cohort.","date":"2020","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32582864","citation_count":51,"is_preprint":false},{"pmid":"18458567","id":"PMC_18458567","title":"Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma.","date":"2008","source":"Journal of pediatric hematology/oncology","url":"https://pubmed.ncbi.nlm.nih.gov/18458567","citation_count":49,"is_preprint":false},{"pmid":"9602167","id":"PMC_9602167","title":"Structural analysis of the human RFC-1 gene encoding a folate transporter reveals multiple promoters and alternatively spliced transcripts with 5' end heterogeneity.","date":"1998","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9602167","citation_count":49,"is_preprint":false},{"pmid":"29577679","id":"PMC_29577679","title":"Removal and biodegradation of different petroleum hydrocarbons using the filamentous fungus Aspergillus sp. RFC-1.","date":"2018","source":"MicrobiologyOpen","url":"https://pubmed.ncbi.nlm.nih.gov/29577679","citation_count":46,"is_preprint":false},{"pmid":"36289003","id":"PMC_36289003","title":"Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome.","date":"2022","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/36289003","citation_count":44,"is_preprint":false},{"pmid":"21438757","id":"PMC_21438757","title":"Association of MTHFR, MTR, MTRR, RFC1, and DHFR gene polymorphisms with susceptibility to sporadic colon cancer.","date":"2011","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21438757","citation_count":44,"is_preprint":false},{"pmid":"32873692","id":"PMC_32873692","title":"Clinical spectrum of the pentanucleotide repeat expansion in the RFC1 gene in ataxia syndromes.","date":"2020","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32873692","citation_count":42,"is_preprint":false},{"pmid":"12753319","id":"PMC_12753319","title":"Effects of the glutamate carboxypeptidase II (GCP2 1561C>T) and reduced folate carrier (RFC1 80G>A) allelic variants on folate and total homocysteine levels in kidney transplant patients.","date":"2003","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/12753319","citation_count":42,"is_preprint":false},{"pmid":"32694621","id":"PMC_32694621","title":"RFC1 repeat expansion in Japanese patients with late-onset cerebellar ataxia.","date":"2020","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32694621","citation_count":41,"is_preprint":false},{"pmid":"21878957","id":"PMC_21878957","title":"Association of MTHFR and RFC1 gene polymorphism with hyperhomocysteinemia and its modulation by vitamin B12 and folic acid in an Indian population.","date":"2011","source":"European journal of clinical nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/21878957","citation_count":41,"is_preprint":false},{"pmid":"24782176","id":"PMC_24782176","title":"RFC1 80G>A is a genetic determinant of methotrexate efficacy in rheumatoid arthritis: a human genome epidemiologic review and meta-analysis of observational studies.","date":"2014","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/24782176","citation_count":41,"is_preprint":false},{"pmid":"9927446","id":"PMC_9927446","title":"Characterization of the repeat-tract instability and mutator phenotypes conferred by a Tn3 insertion in RFC1, the large subunit of the yeast clamp loader.","date":"1999","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9927446","citation_count":40,"is_preprint":false},{"pmid":"18258338","id":"PMC_18258338","title":"Association of RFC1 A80G and MTHFR C677T polymorphisms with Alzheimer's disease.","date":"2008","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/18258338","citation_count":39,"is_preprint":false},{"pmid":"36046423","id":"PMC_36046423","title":"RFC1-Related Disease: Molecular and Clinical Insights.","date":"2022","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36046423","citation_count":38,"is_preprint":false},{"pmid":"21984221","id":"PMC_21984221","title":"The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue.","date":"2011","source":"Cancer chemotherapy and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21984221","citation_count":37,"is_preprint":false},{"pmid":"35883251","id":"PMC_35883251","title":"RFC1 nonsense and frameshift variants cause CANVAS: clues for an unsolved pathophysiology.","date":"2022","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35883251","citation_count":36,"is_preprint":false},{"pmid":"33884451","id":"PMC_33884451","title":"RFC1 AAGGG repeat expansion masquerading as Chronic Idiopathic Axonal Polyneuropathy.","date":"2021","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33884451","citation_count":36,"is_preprint":false},{"pmid":"25778468","id":"PMC_25778468","title":"Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate.","date":"2015","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/25778468","citation_count":36,"is_preprint":false},{"pmid":"9212241","id":"PMC_9212241","title":"Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines.","date":"1997","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9212241","citation_count":35,"is_preprint":false},{"pmid":"25599563","id":"PMC_25599563","title":"Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR , TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis.","date":"2015","source":"Polskie Archiwum Medycyny Wewnetrznej","url":"https://pubmed.ncbi.nlm.nih.gov/25599563","citation_count":33,"is_preprint":false},{"pmid":"18022874","id":"PMC_18022874","title":"Correlation of polymorphism of MTHFRs and RFC-1 genes with neural tube defects in China.","date":"2008","source":"Birth defects research. Part A, Clinical and molecular teratology","url":"https://pubmed.ncbi.nlm.nih.gov/18022874","citation_count":33,"is_preprint":false},{"pmid":"33666721","id":"PMC_33666721","title":"Biallelic RFC1-expansion in a French multicentric sporadic ataxia cohort.","date":"2021","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33666721","citation_count":32,"is_preprint":false},{"pmid":"8512577","id":"PMC_8512577","title":"Cloning and expression of a novel human DNA binding protein, PO-GA.","date":"1993","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8512577","citation_count":30,"is_preprint":false},{"pmid":"9161403","id":"PMC_9161403","title":"Organization, structure and alternate splicing of the murine RFC-1 gene encoding a folate transporter.","date":"1997","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9161403","citation_count":29,"is_preprint":false},{"pmid":"34241918","id":"PMC_34241918","title":"Brain Structural Signature of RFC1-Related Disorder.","date":"2021","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/34241918","citation_count":28,"is_preprint":false},{"pmid":"35013364","id":"PMC_35013364","title":"Biallelic expansion in RFC1 as a rare cause of Parkinson's disease.","date":"2022","source":"NPJ Parkinson's disease","url":"https://pubmed.ncbi.nlm.nih.gov/35013364","citation_count":26,"is_preprint":false},{"pmid":"10375617","id":"PMC_10375617","title":"Isolation and characterization of genomic sequences involved in the regulation of the human reduced folate carrier gene (RFC1).","date":"1999","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10375617","citation_count":26,"is_preprint":false},{"pmid":"17381512","id":"PMC_17381512","title":"Transcriptional regulation of the Drosophila rfc1 gene by the DRE-DREF pathway.","date":"2007","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/17381512","citation_count":24,"is_preprint":false},{"pmid":"36250766","id":"PMC_36250766","title":"New Cerebellar Ataxia, Neuropathy, Vestibular Areflexia Syndrome cases are caused by the presence of a nonsense variant in compound heterozygosity with the pathogenic repeat expansion in the RFC1 gene.","date":"2022","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36250766","citation_count":21,"is_preprint":false},{"pmid":"30142606","id":"PMC_30142606","title":"Biodegradation of n-hexadecane by Aspergillus sp. RFC-1 and its mechanism.","date":"2018","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/30142606","citation_count":21,"is_preprint":false},{"pmid":"27085345","id":"PMC_27085345","title":"The application of GBS markers for extending the dense genetic map of rye (Secale cereale L.) and the localization of the Rfc1 gene restoring male fertility in plants with the C source of sterility-inducing cytoplasm.","date":"2016","source":"Journal of applied genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27085345","citation_count":21,"is_preprint":false},{"pmid":"36705320","id":"PMC_36705320","title":"Association of biallelic RFC1 expansion with early-onset Parkinson's disease.","date":"2023","source":"European journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/36705320","citation_count":20,"is_preprint":false},{"pmid":"9500202","id":"PMC_9500202","title":"Variable expression of RFC1 in human leukemia cell lines resistant to antifolates.","date":"1998","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/9500202","citation_count":20,"is_preprint":false},{"pmid":"18797703","id":"PMC_18797703","title":"Reduced folate carrier 1 (RFC1) is associated with cleft of the lip only.","date":"2008","source":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas","url":"https://pubmed.ncbi.nlm.nih.gov/18797703","citation_count":20,"is_preprint":false},{"pmid":"19274320","id":"PMC_19274320","title":"A80G polymorphism of reduced folate carrier 1 (RFC1) and C776G polymorphism of transcobalamin 2 (TC2) genes in Down's syndrome etiology.","date":"2008","source":"Sao Paulo medical journal = Revista paulista de medicina","url":"https://pubmed.ncbi.nlm.nih.gov/19274320","citation_count":20,"is_preprint":false},{"pmid":"19729796","id":"PMC_19729796","title":"Investigation of CBS, MTR, RFC-1 and TC polymorphisms as maternal risk factors for Down syndrome.","date":"2009","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/19729796","citation_count":20,"is_preprint":false},{"pmid":"23545592","id":"PMC_23545592","title":"Role of methotrexate polyglutamation and reduced folate carrier 1 (RFC1) gene polymorphisms in clinical assessment indexes.","date":"2013","source":"Drug metabolism and pharmacokinetics","url":"https://pubmed.ncbi.nlm.nih.gov/23545592","citation_count":19,"is_preprint":false},{"pmid":"22493068","id":"PMC_22493068","title":"Two different replication factor C proteins, Ctf18 and RFC1, separately control PCNA-CRL4Cdt2-mediated Cdt1 proteolysis during S phase and following UV irradiation.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22493068","citation_count":19,"is_preprint":false},{"pmid":"37621409","id":"PMC_37621409","title":"RFC1 in an Australasian neurological disease cohort: extending the genetic heterogeneity and implications for diagnostics.","date":"2023","source":"Brain communications","url":"https://pubmed.ncbi.nlm.nih.gov/37621409","citation_count":18,"is_preprint":false},{"pmid":"33745133","id":"PMC_33745133","title":"Biallelic RFC1 pentanucleotide repeat expansions in Greek patients with late-onset ataxia.","date":"2021","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33745133","citation_count":17,"is_preprint":false},{"pmid":"30899306","id":"PMC_30899306","title":"Polymorphisms in MTHFR, MTR, RFC1 and CßS genes involved in folate metabolism and thyroid cancer: a case-control study.","date":"2019","source":"Archives of medical science : AMS","url":"https://pubmed.ncbi.nlm.nih.gov/30899306","citation_count":17,"is_preprint":false},{"pmid":"24333266","id":"PMC_24333266","title":"Epigenetic modulation of RFC1, MHC2TA and HLA-DR in systemic lupus erythematosus: association with serological markers and six functional polymorphisms of one-carbon metabolic pathway.","date":"2013","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/24333266","citation_count":17,"is_preprint":false},{"pmid":"37660923","id":"PMC_37660923","title":"Pathogenic CANVAS-causing but not nonpathogenic RFC1 DNA/RNA repeat motifs form quadruplex or triplex structures.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37660923","citation_count":16,"is_preprint":false},{"pmid":"36524104","id":"PMC_36524104","title":"Whole-Genome and Long-Read Sequencing Identify a Novel Mechanism in RFC1 Resulting in CANVAS Syndrome.","date":"2022","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36524104","citation_count":16,"is_preprint":false},{"pmid":"35001451","id":"PMC_35001451","title":"Motor neuron involvement expands the neuropathological phenotype of late-onset ataxia in RFC1 mutation (CANVAS).","date":"2022","source":"Brain pathology (Zurich, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35001451","citation_count":16,"is_preprint":false},{"pmid":"39231235","id":"PMC_39231235","title":"AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.","date":"2024","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/39231235","citation_count":15,"is_preprint":false},{"pmid":"36061987","id":"PMC_36061987","title":"Multi-type RFC1 repeat expansions as the most common cause of hereditary sensory and autonomic neuropathy.","date":"2022","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/36061987","citation_count":14,"is_preprint":false},{"pmid":"38789445","id":"PMC_38789445","title":"Profiling complex repeat expansions in RFC1 in Parkinson's disease.","date":"2024","source":"NPJ Parkinson's disease","url":"https://pubmed.ncbi.nlm.nih.gov/38789445","citation_count":14,"is_preprint":false},{"pmid":"31617429","id":"PMC_31617429","title":"Association of MTHFR and RFC1 gene polymorphisms with methotrexate efficacy and toxicity in Chinese Han patients with rheumatoid arthritis.","date":"2019","source":"The Journal of international medical research","url":"https://pubmed.ncbi.nlm.nih.gov/31617429","citation_count":14,"is_preprint":false},{"pmid":"11162445","id":"PMC_11162445","title":"Down-regulation of reduced folate carrier gene (RFC1) expression after exposure to methotrexate in ZR-75-1 breast cancer cells.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11162445","citation_count":14,"is_preprint":false},{"pmid":"23857226","id":"PMC_23857226","title":"The reduced folate carrier (RFC-1) 80A>G polymorphism and maternal risk of having a child with Down syndrome: a meta-analysis.","date":"2013","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/23857226","citation_count":14,"is_preprint":false},{"pmid":"26819637","id":"PMC_26819637","title":"The association between RFC1 G80A polymorphism and cancer susceptibility: Evidence from 33 studies.","date":"2016","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26819637","citation_count":13,"is_preprint":false},{"pmid":"34537679","id":"PMC_34537679","title":"Investigating RFC1 expansions in sporadic amyotrophic lateral sclerosis.","date":"2021","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34537679","citation_count":13,"is_preprint":false},{"pmid":"28994615","id":"PMC_28994615","title":"MTRR A66G, RFC1 G80A, and MTHFR C677T and A1298C Polymorphisms and Disease Activity in Mexicans with Rheumatoid Arthritis Treated with Methotrexate.","date":"2017","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/28994615","citation_count":12,"is_preprint":false},{"pmid":"7914507","id":"PMC_7914507","title":"The human DNA-binding protein, PO-GA, is homologous to the large subunit of mouse replication factor C: regulation by alternate 3' processing of mRNA.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/7914507","citation_count":12,"is_preprint":false},{"pmid":"24942095","id":"PMC_24942095","title":"RFC1 and non-syndromic cleft lip with or without cleft palate: an association based study in Italy.","date":"2014","source":"Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/24942095","citation_count":12,"is_preprint":false},{"pmid":"20661649","id":"PMC_20661649","title":"A80G polymorphism of reduced folate carrier 1 (RFC1) gene and head and neck squamous cell carcinoma etiology in Brazilian population.","date":"2010","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/20661649","citation_count":12,"is_preprint":false},{"pmid":"36381255","id":"PMC_36381255","title":"Cognitive Impairment in a Complex Family With AAGGG and ACAGG Repeat Expansions in RFC1 Detected by ExpansionHunter Denovo.","date":"2022","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36381255","citation_count":12,"is_preprint":false},{"pmid":"29435434","id":"PMC_29435434","title":"The study of association between reduced folate carrier 1 (RFC1) polymorphism and non-syndromic cleft lip/palate in Iranian population.","date":"2017","source":"BioImpacts : BI","url":"https://pubmed.ncbi.nlm.nih.gov/29435434","citation_count":12,"is_preprint":false},{"pmid":"23986219","id":"PMC_23986219","title":"The influence of genetic RFC1, MS and MTHFR polymorphisms on the risk of acute lymphoblastic leukemia relapse in children and the adverse effects of methotrexate.","date":"2013","source":"Advances in clinical and experimental medicine : official organ Wroclaw Medical University","url":"https://pubmed.ncbi.nlm.nih.gov/23986219","citation_count":11,"is_preprint":false},{"pmid":"21559995","id":"PMC_21559995","title":"DArT markers tightly linked with the Rfc1 gene controlling restoration of male fertility in the CMS-C system in cultivated rye (Secale cereale L.).","date":"2011","source":"Journal of applied genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21559995","citation_count":11,"is_preprint":false},{"pmid":"9521689","id":"PMC_9521689","title":"Destabilized PCNA trimers suppress defective Rfc1 proteins in vivo and in vitro.","date":"1998","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9521689","citation_count":10,"is_preprint":false},{"pmid":"35633373","id":"PMC_35633373","title":"Screening for RFC-1 pathological expansion in late-onset ataxias: a contribution to the differential diagnosis.","date":"2022","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35633373","citation_count":10,"is_preprint":false},{"pmid":"25659099","id":"PMC_25659099","title":"Association of reduced folate carrier-1 (RFC-1) polymorphisms with ischemic stroke and silent brain infarction.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25659099","citation_count":10,"is_preprint":false},{"pmid":"27213354","id":"PMC_27213354","title":"A Study of Single Nucleotide Polymorphisms of the SLC19A1/RFC1 Gene in Subjects with Autism Spectrum Disorder.","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27213354","citation_count":10,"is_preprint":false},{"pmid":"38627134","id":"PMC_38627134","title":"RFC1: Motifs and phenotypes.","date":"2024","source":"Revue neurologique","url":"https://pubmed.ncbi.nlm.nih.gov/38627134","citation_count":9,"is_preprint":false},{"pmid":"39833204","id":"PMC_39833204","title":"Long-read sequencing revealed complex biallelic pentanucleotide repeat expansions in RFC1-related Parkinson's disease.","date":"2025","source":"NPJ Parkinson's disease","url":"https://pubmed.ncbi.nlm.nih.gov/39833204","citation_count":9,"is_preprint":false},{"pmid":"25536437","id":"PMC_25536437","title":"RFC-1 80G>A polymorphism in case-mother/control-mother dyads is associated with risk of nephroblastoma and neuroblastoma.","date":"2014","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/25536437","citation_count":9,"is_preprint":false},{"pmid":"27936032","id":"PMC_27936032","title":"The RFC1 80G>A, among Common One-Carbon Polymorphisms, Relates to Survival Rate According to DNA Global Methylation in Primary Liver Cancers.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27936032","citation_count":9,"is_preprint":false},{"pmid":"24401732","id":"PMC_24401732","title":"Decitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumors.","date":"2014","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/24401732","citation_count":8,"is_preprint":false},{"pmid":"10231581","id":"PMC_10231581","title":"Transcription of the mouse RFC-1 gene encoding a folate transporter. Multiplicity and properties of promoters with minimum requirements for their basal activity.","date":"1999","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10231581","citation_count":8,"is_preprint":false},{"pmid":"37917284","id":"PMC_37917284","title":"Investigation of RFC1 tandem nucleotide repeat locus in diverse neurodegenerative outcomes in an Indian cohort.","date":"2023","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/37917284","citation_count":7,"is_preprint":false},{"pmid":"38755058","id":"PMC_38755058","title":"Chronic Cough and Cerebellar Ataxia With Neuropathy and Bilateral Vestibular Areflexia Syndrome (CANVAS): Screening for Mutations in Replication Factor C Subunit 1 (RFC1).","date":"2024","source":"Archivos de bronconeumologia","url":"https://pubmed.ncbi.nlm.nih.gov/38755058","citation_count":7,"is_preprint":false},{"pmid":"9689927","id":"PMC_9689927","title":"Chromosomal localization of the murine RFC-1 gene encoding a folate transporter and its amplification in an antifolate resistant variant overproducing the transporter.","date":"1998","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/9689927","citation_count":7,"is_preprint":false},{"pmid":"38062616","id":"PMC_38062616","title":"RNA Foci in Two bi-Allelic RFC1 Expansion Carriers.","date":"2023","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/38062616","citation_count":6,"is_preprint":false},{"pmid":"39811557","id":"PMC_39811557","title":"Repeat expansions in RFC1 gene in refractory chronic cough.","date":"2025","source":"ERJ open research","url":"https://pubmed.ncbi.nlm.nih.gov/39811557","citation_count":6,"is_preprint":false},{"pmid":"27222703","id":"PMC_27222703","title":"Association Between RFC1 G80A Polymorphism and Acute Lymphoblastic Leukemia: a Review and Meta-Analysis of 10 Studies.","date":"2016","source":"Iranian journal of pediatric hematology and oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27222703","citation_count":6,"is_preprint":false},{"pmid":"15231126","id":"PMC_15231126","title":"[Study on reduced folate carrier gene (RFC1) polymorphism in the southern and northern Chinese population].","date":"2004","source":"Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi","url":"https://pubmed.ncbi.nlm.nih.gov/15231126","citation_count":6,"is_preprint":false},{"pmid":"16086047","id":"PMC_16086047","title":"[Epidemiological study on reduced folate carrier gene(RFC1 A80G) polymorphism and other risk factors of neural tube defects].","date":"2005","source":"Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/16086047","citation_count":6,"is_preprint":false},{"pmid":"33188504","id":"PMC_33188504","title":"Spasmodic cough preceding CANVAS phenotype in a family with biallelic repeat expansions in RFC1.","date":"2020","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/33188504","citation_count":6,"is_preprint":false},{"pmid":"38168171","id":"PMC_38168171","title":"AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS Neurons.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38168171","citation_count":5,"is_preprint":false},{"pmid":"33749319","id":"PMC_33749319","title":"Influence of RFC1 c.80A>G Polymorphism on Methotrexate-Mediated Toxicity and Therapeutic Efficacy in Rheumatoid Arthritis: A Meta-analysis.","date":"2021","source":"The Annals of pharmacotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/33749319","citation_count":5,"is_preprint":false},{"pmid":"35306791","id":"PMC_35306791","title":"Expanding the Clinical Spectrum of RFC1 Gene Mutations.","date":"2022","source":"Journal of movement disorders","url":"https://pubmed.ncbi.nlm.nih.gov/35306791","citation_count":5,"is_preprint":false},{"pmid":"38685975","id":"PMC_38685975","title":"RFC1 Repeat Distribution in the Cypriot Population: Study of a Large Cohort of Patients With Undiagnosed Ataxia and Non-Disease Controls.","date":"2024","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38685975","citation_count":5,"is_preprint":false},{"pmid":"11129041","id":"PMC_11129041","title":"Allele-specific interactions between the yeast RFC1 and RFC5 genes suggest a basis for RFC subunit-subunit interactions.","date":"2000","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/11129041","citation_count":5,"is_preprint":false},{"pmid":"19548564","id":"PMC_19548564","title":"[Relationship between genetic polymorphisms of RFC1 A80G and nonsymdromic cleft lip with or without palate].","date":"2009","source":"Wei sheng yan jiu = Journal of hygiene research","url":"https://pubmed.ncbi.nlm.nih.gov/19548564","citation_count":5,"is_preprint":false},{"pmid":"35585435","id":"PMC_35585435","title":"Beyond canvas: behavioral onset of rfc1-expansion disease in an Italian family-causal or casual?","date":"2022","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/35585435","citation_count":5,"is_preprint":false},{"pmid":"38898197","id":"PMC_38898197","title":"An Updated Canvas of the RFC1-mediated CANVAS (Cerebellar Ataxia, Neuropathy and Vestibular Areflexia Syndrome).","date":"2024","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/38898197","citation_count":4,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53690,"output_tokens":6527,"usd":0.129488,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15761,"output_tokens":4147,"usd":0.09124,"stage2_stop_reason":"end_turn"},"total_usd":0.220728,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"PO-GA (RFC1) was identified as a human DNA-binding protein that selectively binds GA-rich double-stranded DNA sequences and certain single-stranded DNA sequences. The protein has regions of homology to E. coli and yeast DNA ligases and to proteins involved in DNA repair, suggesting roles in transcription, DNA repair, or replication.\",\n      \"method\": \"HeLa cDNA expression library screening with cognate DNA binding site; E. coli expression and DNA-binding assay; Northern blot\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single lab, direct DNA-binding assay in vitro, but limited functional follow-up; no mutagenesis or reconstitution\",\n      \"pmids\": [\"8512577\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"PO-GA was shown to be 80% identical at the amino-acid level to the large subunit of mouse replication factor C (RFC), establishing it as the human RFC1 large subunit. The protein contains a nuclear translocation signal and an ATP/ADP-binding motif. Two mRNA species (5.3 kb and 4.5 kb) arise from alternate use of poly(A)-addition sites, with expression levels varying by tissue.\",\n      \"method\": \"DNA sequence database comparison; Northern blot of human tissues; cDNA sequence analysis of 3'-UTR\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — sequence identity establishes orthology, alternate poly(A) site mechanism shown by sequence analysis and Northern blot, single lab\",\n      \"pmids\": [\"7914507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"RFC1 encodes the reduced folate carrier protein responsible for methotrexate (MTX) uptake in human breast cancer cells. Decreased RFC1 expression was the molecular mechanism of decreased MTX uptake in MTX-resistant ZR-75-1 cells; transfection with RFC1 restored MTX uptake with folinic acid competition preference over folic acid.\",\n      \"method\": \"Northern blot; Western blot with anti-RFC1 peptide antibody; cDNA transfection into transport-deficient cells; MTX uptake competition assay; FISH chromosomal mapping\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Western, Northern, functional transfection rescue, uptake assay) in single lab; finding replicated across multiple subsequent papers\",\n      \"pmids\": [\"7641195\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"RFC1 functions as a bidirectional anion exchanger/reduced folate carrier. High-level RFC1 overexpression via transfection increased MTX influx ~9-fold and efflux ~5-fold but produced only a modest (~2-fold) increase in steady-state intracellular MTX, consistent with RFC1 being intrinsically equilibrating rather than concentrative. Free intracellular folate levels, not influx rate, determined antifolate activity.\",\n      \"method\": \"cDNA transfection of RFC1 into MTXrA carrier-null cells; radiolabeled MTX influx/efflux kinetics; intracellular MTX concentration measurement; IC50 determination\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — quantitative transport reconstitution by transfection with kinetic analysis; multiple functional readouts; consistent with structural model of bidirectional exchanger\",\n      \"pmids\": [\"9261128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The murine RFC-1 gene spans 10.4 kb and is distributed in eight exons including alternates of exon 1 and exon 5. Splice variants encoding polypeptides of 58, 53.6, and 43.4 kDa arise from alternate exon usage. A GC-rich region 5' of exon 1 contains promoter-like elements. Two distinct promoters drive RFC-1 transcription.\",\n      \"method\": \"Genomic DNA sequencing; cDNA library screening; splice variant identification; gene structure mapping\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — structural genomic characterization of gene organization and splice variants; functional promoter activity not yet tested in this paper\",\n      \"pmids\": [\"9161403\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"A glutamate-to-lysine mutation at amino acid 45 (E45K) in the first predicted transmembrane domain of murine RFC1 markedly altered substrate specificity: folic acid influx doubled while MTX and 5-CHO-THF influx decreased. The E45K mutant carrier required small inorganic anions (chloride, fluoride, nitrate) for transport function, whereas the wild-type did not show this obligatory anion requirement. This indicates that the first transmembrane domain is critical for determining the spectrum of substrate affinities and carrier mobility.\",\n      \"method\": \"cDNA transfection of RFC1-E45K into carrier-null MTXrA cells; radiolabeled substrate influx assays; anion substitution experiments; inhibition kinetics\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — site-specific mutation reconstituted in null background with multiple substrate and anion-replacement experiments; mechanistic interpretation supported by quantitative kinetics\",\n      \"pmids\": [\"9668089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"A single amino acid difference at codon 297 (Ser in L1210 vs. Asn in S180 cells), located between transmembrane helices 7 and 8, accounts for a 4-fold higher influx Km for MTX in S180 cells without affecting Vmax or efflux. This residue is on or near the external substrate-binding site and selectively affects N1O-substituted folate analogues. The topology analysis places the codon-297 region on the external plasma membrane surface.\",\n      \"method\": \"Nucleotide sequencing of cDNA and genomic DNA; cDNA transfection of S180 vs. L1210 RFC-1 cDNAs into carrier-null L1210 variant; radiolabeled MTX/aminopterin influx Km measurements; Western blot; topology analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — single nucleotide difference identified and functionally confirmed by reciprocal cDNA transfection into null background with quantitative kinetics\",\n      \"pmids\": [\"9446553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The human RFC-1 gene spans 22.5 kb and contains eight exons including three alternatives of exon 1 (1a, 1b, 1c). Two distinct promoters were identified upstream of exons 1a/1c and 1b respectively by functional deletion analysis. Promoter 1 (upstream of exon 1a) had ~3-fold lower basal activity than promoter 2 (upstream of exon 1b), but was enhanced up to 9-fold with an SV40 enhancer. Promoter 2 contains a GC-rich direct repeat with Sp1 and MZF1 sites.\",\n      \"method\": \"Genomic DNA sequencing; primer extension analysis; luciferase reporter gene transient transfection in two human cell types; functional deletion analysis\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dual-promoter activity demonstrated by reporter assays in cells; primer extension confirms multiple transcription start sites; single lab\",\n      \"pmids\": [\"9602167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"A mutation in the large subunit of yeast RFC (rfc1-1, D513N) within the conserved RFC box VIII sequence causes DNA replication defects, increased sensitivity to DNA-damaging agents, elongated telomeres, and in vitro DNA replication defects. Destabilized PCNA trimers (mutant PCNA) suppress the in vitro replication defects of rfc1-1 mutant complexes in an ATP-concentration-sensitive manner, suggesting that RFC1-PCNA interaction and PCNA clamp loading are mechanistically linked.\",\n      \"method\": \"Yeast genetics; in vitro DNA replication assay; PCNA mutant suppressor analysis; DNA damage sensitivity assay; telomere length analysis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of replication defect with defined mutation; PCNA suppression tested biochemically; multiple in vivo phenotypes\",\n      \"pmids\": [\"9521689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"RFC1 gene copy number amplification at a homogeneously staining region (HSR) in a chromosome 10 locus in the L1210/R83 variant underlies a 30-35-fold increase in RFC-1 mRNA and a 35-fold increase in MTX transport Vmax. Chromosomal localization of murine RFC-1 gene is on chromosome 10B3 in association with the Col18a1 collagen gene.\",\n      \"method\": \"Southern blot (gene copy number); Northern blot (mRNA levels); FISH (chromosomal localization and HSR identification); MTX influx Vmax measurement; karyotype analysis\",\n      \"journal\": \"Cancer genetics and cytogenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — FISH directly localized amplified RFC-1 to HSR; multiple orthogonal methods in single lab; functional correlation between gene dosage and transport capacity\",\n      \"pmids\": [\"9689927\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The rfc1::Tn3 (large subunit of yeast clamp loader RFC) mutant displays a mutator phenotype and repeat-tract instability. Genetic epistasis analysis shows that rfc1::Tn3 is synthetically lethal with pol30 (PCNA), pol3 (DNA Pol δ), and rad27 (Fen1) mutations. The rfc1::Tn3 forward mutation frequency is nearly multiplicative with mismatch repair mutants (msh2Δ, pms1Δ), but its repeat-tract instability phenotype is epistatic to mismatch repair mutants, indicating RFC1 generates replication errors that are partially corrected by MMR.\",\n      \"method\": \"Yeast genetic screen; forward mutation assay; repeat-tract instability assay; double and triple mutant analysis with msh2Δ, pms1Δ, rad52, pol3-01, pol30-52, rth1Δ/rad27Δ; synthetic lethality testing\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple epistasis combinations tested with defined alleles; quantitative mutation frequency in double mutants; clear pathway placement of RFC1 relative to MMR and DNA replication\",\n      \"pmids\": [\"9927446\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"RFC1 RNA levels are cell-cycle regulated and peak at the G1-to-S transition. Differential transcription from multiple RFC1 5' non-coding exons occurs in different tissues, during development, and in MTX-resistant cells. Genomic sequences upstream of exons 1b and 1c contain functional promoter elements, identified by promoter-reporter fusion constructs.\",\n      \"method\": \"Semi-quantitative RT-PCR with exon-specific primers; RFC1 promoter-reporter fusion constructs; Northern blot\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional promoter activity demonstrated; cell cycle regulation established by RT-PCR across cell cycle stages; single lab\",\n      \"pmids\": [\"10375617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Two promoters regulating mouse RFC-1 gene expression were functionally characterized. The promoter upstream of exon 1 (stronger) and the promoter upstream of exon 1a (weaker) each rely on closely spaced tandem Sp1 sites for basal promoter activity, as demonstrated by site-directed mutagenesis and DNase I footprinting. A poly(GT)21 dinucleotide repeat upstream of the Sp1 sites suppresses transcription when deleted.\",\n      \"method\": \"Luciferase reporter gene transient transfection in NIH3T3 cells; site-directed mutagenesis of Sp1 sites; DNase I footprinting analysis\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — site-directed mutagenesis with reporter assay and footprinting confirms Sp1-dependent mechanism; single lab\",\n      \"pmids\": [\"10231581\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Exposure of ZR-75-1 breast cancer cells to low-dose MTX caused transcriptional down-regulation of RFC1: RFC1 RNA and protein levels decreased to ~22% of baseline, and promoter-reporter assays showed decreased activity of RFC1 promoter elements. This down-regulation was not due to DNA methylation of the RFC1 promoter (5-azacytidine pretreatment did not restore RFC1 activity).\",\n      \"method\": \"Western blot; Northern blot; RT-PCR with exon-specific primers; promoter-reporter construct assays; MTX uptake measurement; 5-azacytidine pretreatment experiment\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (Western, Northern, RT-PCR, reporter assay) demonstrating transcriptional down-regulation; negative result on methylation mechanism informative; single lab\",\n      \"pmids\": [\"11162445\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Allele-specific genetic interactions between yeast RFC1 and RFC5 genes were identified: RFC5 mutations in conserved RFC box motifs IV-VII suppress the cold-sensitive growth phenotype of rfc1-1 mutants but cannot suppress its elongated telomere, DNA-damage sensitivity, or mutator phenotypes. RFC5 suppressor mutations do not interfere with checkpoint signaling (Rad53p phosphorylation). This defines distinct functional contributions of RFC1 and RFC5 to telomere maintenance, DNA repair, and viability versus checkpoint function.\",\n      \"method\": \"Yeast genetics; allele-specific suppressor isolation; phenotypic analysis (growth, DNA damage sensitivity, telomere length, mutation frequency); Rad53p phosphorylation assay (Western blot)\",\n      \"journal\": \"Molecular & general genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — allele-specific suppression with multiple phenotypic readouts; clear genetic dissection of RFC1 functions; single lab\",\n      \"pmids\": [\"11129041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Drosophila rfc1 gene (encoding dRFC140, the large RFC subunit) is transcriptionally regulated by the DRE-DREF pathway. Three DRE-like sequences in the rfc1 promoter bind DREF in vitro (EMSA with nuclear extracts) and in vivo (chromatin immunoprecipitation). Luciferase reporter assays confirm that DREs are required for full rfc1 promoter activity in S2 cells; DREF dsRNA knockdown reduced rfc1 promoter activity by 38%. Immunostaining shows rfc1 expression correlates with cell-cycle stage.\",\n      \"method\": \"Band-mobility shift assay (EMSA); chromatin immunoprecipitation; luciferase transient expression assay in S2 cells; DREF dsRNA knockdown; immunostaining of polytene chromosomes and larval tissues\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (EMSA, ChIP, reporter assay, RNAi) converging on DRE-DREF regulation; in vivo and in vitro concordance; single lab\",\n      \"pmids\": [\"17381512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RFC1-RFC (the canonical clamp loader) is required for PCNA-CRL4(Cdt2)-mediated Cdt1 degradation specifically after UV irradiation (during nucleotide excision repair), but not during S phase. A distinct RFC complex, Ctf18-RFC, is required for Cdt1 degradation during S phase. Thus, different RFC complexes differentially control CRL4(Cdt2)-dependent proteolysis of Cdt1 during replication versus repair.\",\n      \"method\": \"siRNA depletion of RFC1 and Ctf18 in human cells; flow cytometry and Western blot of Cdt1 stability; chromatin fractionation for PCNA loading; re-replication assay; Cdt1 degron mutant constructs\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean siRNA knockdown with defined phenotype; multiple cell-cycle and repair conditions tested; pathway placement by depletion of individual RFC complex components with specific readout\",\n      \"pmids\": [\"22493068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Biallelic intronic AAGGG repeat expansion in RFC1 intron 2 (within the poly(A) tail of an AluSx3 element) is the genetic cause of CANVAS and late-onset ataxia. Critically, the expansion does not affect RFC1 expression in patient peripheral and brain tissue, suggesting the pathogenic mechanism is not simple loss of RFC1 protein function.\",\n      \"method\": \"Non-parametric linkage analysis; genome sequencing; quantitative expression analysis in patient peripheral and brain tissue; repeat-primed PCR; Southern blot\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide linkage analysis followed by molecular characterization in multiple families; expression analysis in patient tissues; widely replicated across subsequent studies\",\n      \"pmids\": [\"30926972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Truncating variants (nonsense and frameshift) in RFC1, when compound heterozygous with the AAGGG repeat expansion, cause CANVAS. Patient fibroblasts with truncating variants show nonsense-mediated mRNA decay and reduced RFC1 transcript and protein levels, providing evidence that a loss-of-function mechanism underlies RFC1-related CANVAS.\",\n      \"method\": \"Whole-genome/exome sequencing; RT-PCR quantification of RFC1 transcript; Western blot of RFC1 protein in patient fibroblasts; nonsense-mediated decay assessment\",\n      \"journal\": \"Neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple independent families; direct measurement of transcript and protein in patient-derived cells; multiple truncating variants with concordant NMD; replicated across two independent papers (PMIDs 36289003, 35883251)\",\n      \"pmids\": [\"36289003\", \"35883251\", \"36524104\", \"36250766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RFC1 expression studies in whole blood from CANVAS patients compound heterozygous for truncating variants and AAGGG expansion showed significantly reduced RFC1 mRNA compared with patients carrying biallelic RFC1 expansions alone, providing additional evidence for conditional loss-of-function as a disease mechanism.\",\n      \"method\": \"Quantitative RT-PCR of RFC1 mRNA in patient whole blood; clinical exome sequencing; repeat-primed PCR for expansion identification\",\n      \"journal\": \"Brain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — quantitative mRNA measurement in patient blood; single lab; limited sample size (n=2 truncating variant patients vs. 3 biallelic expansion patients)\",\n      \"pmids\": [\"35883251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Pathogenic CANVAS-causing RFC1 repeat motifs (AAGGG and ACAGG) but not nonpathogenic motifs (AAAAG) form G-quadruplex structures (in potassium solution) and triple-stranded structures. The pathogenic motif r(AAGGG)4 forms G-quadruplexes detectable with the ligand TMPyP4. Nonpathogenic repeats do not form these structures. This supports toxic-DNA and toxic-RNA modes of pathogenesis via unusual nucleic acid secondary structures.\",\n      \"method\": \"In vitro biophysical characterization of synthetic DNA/RNA oligonucleotides; G-quadruplex detection in potassium solution; triplex structure formation assays; TMPyP4 ligand-binding assay; computational analysis of hydrogen bonds and pi-stacking\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with defined oligonucleotides; multiple structural assays; single lab; correlative link to pathogenicity requires further cellular validation\",\n      \"pmids\": [\"37660923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CCCTT/AAGGG repeat expansions in CANVAS patient iPSC-derived neurons do not alter RFC1 splicing, expression, or DNA repair pathway function. CANVAS iNeurons exhibit defects in neuronal development and diminished synaptic connectivity that is rescued by CRISPR deletion of a single expanded AAGGG allele. These neuronal deficits were NOT replicated by RFC1 knockdown in control neurons and were NOT rescued by RFC1 reprovision, establishing that the pathogenic mechanism is repeat-dependent but RFC1 protein-independent.\",\n      \"method\": \"Patient iPSC-derived neuron generation; calcium imaging; transcriptomics; CRISPR allele deletion; RFC1 knockdown (siRNA/shRNA); RFC1 overexpression/reprovision; RT-PCR for RFC1 splicing; DNA repair pathway functional assays\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods; CRISPR rescue confirms repeat dependence; RFC1 knockdown/reprovision negative results are mechanistically informative; replicated in preprint (PMID 38168171)\",\n      \"pmids\": [\"39231235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CCCTT- and CCCGT-containing RNA foci were detected by RNA FISH in neuronal nuclei of tissues with neuronal loss in two autopsy CANVAS patients with biallelic ACAGG and AAGGG expansions, respectively. This suggests that RNA toxicity (toxic RNA gain-of-function) may contribute to CANVAS pathogenesis.\",\n      \"method\": \"RNA fluorescence in situ hybridization (FISH) on autopsy tissue; neuropathological analysis\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab; only two autopsy cases; correlative finding without functional manipulation to establish causality\",\n      \"pmids\": [\"38062616\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RFC1 encodes the large subunit of the replication factor C (RFC) clamp loader complex, which loads the PCNA sliding clamp onto DNA at primer-template junctions in an ATP-dependent manner and is required for DNA replication fidelity, repair, and telomere maintenance; it also functions as a bidirectional anion exchanger/reduced folate carrier (SLC19A1) at the plasma membrane, transporting reduced folates and antifolates including methotrexate via a mechanism requiring the first transmembrane domain for substrate selectivity; RFC1-RFC specifically mediates PCNA-CRL4(Cdt2)-dependent Cdt1 proteolysis after UV damage but not during S phase; biallelic intronic AAGGG repeat expansions cause CANVAS via a repeat-dependent but RFC1 protein-independent mechanism (neuronal synaptic dysfunction rescued by CRISPR deletion of expanded alleles but not by RFC1 knockdown/reprovision), with pathogenic repeat motifs forming G-quadruplex and triplex structures in vitro, while truncating variants in compound heterozygosity with the expansion cause disease through partial RFC1 loss-of-function via nonsense-mediated mRNA decay.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RFC1 encodes the large subunit of the replication factor C (RFC) clamp loader, an ATP-utilizing complex that loads the PCNA sliding clamp onto DNA and thereby underpins DNA replication fidelity, repair, and telomere maintenance [#8, #10]. It was first cloned as a GA-rich DNA-binding protein carrying an ATP/ADP-binding motif and nuclear localization signal, and assigned as the human ortholog of the mouse RFC large subunit [#0, #1]. Yeast genetics establishes the mechanistic core: RFC1 mutation produces DNA replication defects, DNA-damage sensitivity, elongated telomeres and a mutator/repeat-instability phenotype, and RFC1 is synthetically lethal with PCNA, DNA Pol \\u03b4 and Fen1, with destabilized PCNA trimers suppressing its replication defect \\u2014 directly coupling RFC1 to PCNA clamp loading [#8, #10]; allele-specific interactions with RFC5 further partition RFC1's roles in telomere maintenance, repair and viability from checkpoint signaling [#14]. RFC1 RNA peaks at the G1-to-S transition under control of dual GC-rich, Sp1-dependent promoters, a cell-cycle program conserved through the Drosophila DRE-DREF pathway [#11, #12, #15]. Within the clamp-loader family, RFC1-RFC selectively drives PCNA-CRL4(Cdt2)-mediated Cdt1 degradation after UV damage, whereas Ctf18-RFC handles Cdt1 turnover during S phase [#16]. Independently, the same locus (SLC19A1) encodes the reduced folate carrier, a bidirectional, equilibrating anion exchanger at the plasma membrane that mediates uptake of reduced folates and antifolates including methotrexate; its first transmembrane domain (E45) determines substrate selectivity and anion dependence, and a residue near helices 7-8 (codon 297) tunes the influx Km for N10-substituted folates [#2, #3, #5, #6]. Biallelic intronic AAGGG repeat expansions in RFC1 cause CANVAS and late-onset ataxia without altering RFC1 expression [#17]; iPSC-neuron work shows the synaptic and developmental deficits are rescued by CRISPR deletion of the expanded allele but not reproduced by RFC1 knockdown or rescued by RFC1 reprovision, establishing a repeat-dependent, RFC1-protein-independent mechanism [#21], with pathogenic motifs forming G-quadruplex and triplex structures in vitro [#20]. In compound heterozygosity with the expansion, truncating variants cause disease through partial loss of function via nonsense-mediated mRNA decay [#18, #19].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing that the cloned GA-rich DNA-binding protein PO-GA is the human RFC large subunit answered what this protein is and pointed toward replication/repair function via its ATP-binding motif.\",\n      \"evidence\": \"cDNA expression cloning by DNA-binding, sequence comparison to mouse RFC, Northern blot of human tissues\",\n      \"pmids\": [\"8512577\", \"7914507\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"DNA-binding specificity not linked to a defined replication step\", \"No reconstitution of clamp-loading activity\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrating that the same locus encodes the reduced folate carrier resolved its second identity as a membrane transporter and explained methotrexate uptake and resistance.\",\n      \"evidence\": \"cDNA transfection rescue of transport-deficient cells, MTX influx/efflux kinetics, uptake competition assays\",\n      \"pmids\": [\"7641195\", \"9261128\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transport mechanism (equilibrating vs concentrative) defined functionally but not structurally\", \"Relationship between transporter role and RFC clamp-loader role unexplained\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Site-directed and natural variant analysis mapped the structural determinants of folate/antifolate substrate selectivity, showing specific transmembrane residues set substrate spectrum and anion dependence.\",\n      \"evidence\": \"E45K and codon-297 mutants reconstituted in carrier-null cells with substrate influx Km/Vmax and anion-substitution kinetics\",\n      \"pmids\": [\"9668089\", \"9446553\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of the carrier\", \"Full transport cycle not modeled\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Yeast genetics placed RFC1 mechanistically within PCNA clamp loading and replication-error suppression, defining its epistatic relationships with PCNA, Pol \\u03b4, Fen1 and mismatch repair and separating its functions from checkpoint signaling.\",\n      \"evidence\": \"Yeast rfc1 mutants/Tn3 alleles, in vitro replication assays with PCNA suppressors, synthetic lethality and mutation-frequency epistasis, allele-specific RFC5 suppression\",\n      \"pmids\": [\"9521689\", \"9927446\", \"11129041\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Human RFC1 clamp-loading not directly reconstituted in these studies\", \"Telomere maintenance role mechanistically undefined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Promoter and cell-cycle expression analysis showed RFC1 transcription is coordinated with the G1/S transition through Sp1-dependent dual promoters, a regulatory logic conserved to the Drosophila DRE-DREF pathway.\",\n      \"evidence\": \"RT-PCR across cell cycle, reporter/footprinting promoter dissection, EMSA/ChIP/RNAi in Drosophila S2 cells\",\n      \"pmids\": [\"10375617\", \"10231581\", \"9602167\", \"17381512\", \"11162445\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Upstream signals coupling RFC1 transcription to cell-cycle machinery not fully defined\", \"MTX-induced down-regulation mechanism (non-methylation) incomplete\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Distinguishing RFC1-RFC from Ctf18-RFC in CRL4(Cdt2)-dependent Cdt1 proteolysis defined a context-specific role for canonical RFC in coupling PCNA loading to ubiquitin-mediated degradation after UV damage rather than during S phase.\",\n      \"evidence\": \"siRNA depletion of RFC1 vs Ctf18 in human cells, Cdt1 stability by Western/flow, chromatin fractionation, re-replication assay\",\n      \"pmids\": [\"22493068\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of why RFC1-RFC acts only in repair context unknown\", \"Direct interaction with CRL4(Cdt2) not structurally resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linkage and genome sequencing identified biallelic intronic AAGGG repeat expansion as the cause of CANVAS, and the absence of expression change reframed the question away from simple RFC1 loss.\",\n      \"evidence\": \"Non-parametric linkage, genome sequencing, repeat-primed PCR/Southern, expression analysis in patient tissues\",\n      \"pmids\": [\"30926972\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Pathogenic mechanism of the repeat not established\", \"Cell type and pathway driving neurodegeneration unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identification of truncating variants in trans with the expansion, with NMD and reduced transcript/protein, established that a partial loss-of-function mechanism contributes to RFC1-related CANVAS.\",\n      \"evidence\": \"Exome/genome sequencing across families, RT-PCR transcript quantification, Western blot in patient fibroblasts and blood\",\n      \"pmids\": [\"36289003\", \"35883251\", \"36524104\", \"36250766\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Reconciliation of loss-of-function with normal expression in biallelic-expansion patients incomplete\", \"Quantitative dosage threshold for disease unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Biophysical and neuropathological work characterized the molecular nature of the repeat, showing pathogenic motifs uniquely form G-quadruplex/triplex structures and produce nuclear RNA foci, supporting toxic-DNA/RNA modes.\",\n      \"evidence\": \"In vitro G-quadruplex/triplex assays on synthetic oligonucleotides, RNA FISH on autopsy tissue\",\n      \"pmids\": [\"37660923\", \"38062616\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal link between secondary structures and neuronal toxicity not established in vivo\", \"RNA foci finding limited to two autopsy cases\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"iPSC-neuron modeling resolved the CANVAS mechanism as repeat-dependent but RFC1-protein-independent, since allele deletion rescued synaptic deficits while RFC1 knockdown failed to phenocopy and reprovision failed to rescue.\",\n      \"evidence\": \"Patient iPSC-derived neurons, calcium imaging, transcriptomics, CRISPR allele deletion, RFC1 knockdown and overexpression, DNA-repair assays\",\n      \"pmids\": [\"39231235\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the toxic species (DNA vs RNA vs RAN product) not pinned down\", \"How repeat toxicity converges on synaptic connectivity unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how the repeat-dependent toxic mechanism mechanistically reconciles with the loss-of-function contribution of truncating variants, and what the toxic molecular species is.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking expansion toxicity and partial loss-of-function\", \"Toxic species and its cellular target not identified\", \"No structural model of human RFC1 clamp-loader function in this corpus\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [8, 1]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [2, 3, 5, 6]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 8]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 5, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [8, 10]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [16, 10]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [2, 3, 5]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [17, 18, 21]}\n    ],\n    \"complexes\": [\"Replication factor C (RFC) clamp loader\"],\n    \"partners\": [\"PCNA\", \"RFC5\", \"CDT1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}